These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 26295863)

  • 21. A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis.
    Bernard LA; Cunningham BB; Al-Suwaidan S; Friedlander SF; Eichenfield LF
    Arch Dermatol; 2003 Feb; 139(2):229-31. PubMed ID: 12588240
    [No Abstract]   [Full Text] [Related]  

  • 22. Pimecrolimus 1% cream for the treatment of rosacea.
    Kim MB; Kim GW; Park HJ; Kim HS; Chin HW; Kim SH; Kim BS; Ko HC
    J Dermatol; 2011 Dec; 38(12):1135-9. PubMed ID: 21954922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of topical calcineurin inhibitors in vitiligo.
    Wong R; Lin AN
    Int J Dermatol; 2013 Apr; 52(4):491-6. PubMed ID: 23331250
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pimecrolimus for treatment of acne rosacea.
    Crawford KM; Russ B; Bostrom P
    Skinmed; 2005; 4(3):147-50. PubMed ID: 15891250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Steroid-aggravated rosacea: successful therapy with pimecrolimus].
    Meykadeh N; Meiss F; Marsch WC; Fischer M
    Hautarzt; 2007 Apr; 58(4):338-42. PubMed ID: 16874534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rosaceiform dermatitis with follicular Demodex after treatment of facial atopic dermatitis with 1% pimecrolimus cream.
    Lübbe J; Stucky L; Saurat JH
    Dermatology; 2003; 207(2):204-5. PubMed ID: 12920379
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of metronidazole 1% cream and pimecrolimus 1% cream in the treatment of patients with papulopustular rosacea: a randomized open-label clinical trial.
    Koca R; Altinyazar HC; Ankarali H; Muhtar S; Tekin NS; Cinar S
    Clin Exp Dermatol; 2010 Apr; 35(3):251-6. PubMed ID: 19594764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
    Lonsdale-Eccles AA; Velangi S
    Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Topical calcineurin inhibitors as a double-edged sword in rosacea: A systematic review.
    Zhang H; Yang L; Wang Y; Zhang D; Tang K; Fang R; Sun Q
    J Cosmet Dermatol; 2022 Apr; 21(4):1695-1704. PubMed ID: 34192412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innovative use of topical calcineurin inhibitors.
    Lin AN
    Dermatol Clin; 2010 Jul; 28(3):535-45. PubMed ID: 20510763
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tacrolimus-induced rosacea-like dermatitis: a clinical analysis of 16 cases associated with tacrolimus ointment application.
    Teraki Y; Hitomi K; Sato Y; Izaki S
    Dermatology; 2012; 224(4):309-14. PubMed ID: 22626964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pimecrolimus, a topical calcineurin inhibitor used in the treatment of atopic eczema.
    Prucha H; Schnopp C; Akdis C; Lauener R; Wollenberg A; Ring J; Traidl-Hoffmann C
    Expert Opin Drug Metab Toxicol; 2013 Nov; 9(11):1507-16. PubMed ID: 23876065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update of calcineurin inhibitors to treat inverse psoriasis: A systematic review.
    Dattola A; Silvestri M; Bennardo L; Del Duca E; Longo C; Bianchi L; Nisticò S
    Dermatol Ther; 2018 Nov; 31(6):e12728. PubMed ID: 30295379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spotlight on topical pimecrolimus in pediatric atopic dermatitis.
    Yang LP; Curran MP
    Am J Clin Dermatol; 2010; 11(4):295-8. PubMed ID: 20509720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial.
    Weissenbacher S; Merkl J; Hildebrandt B; Wollenberg A; Braeutigam M; Ring J; Hofmann H
    Br J Dermatol; 2007 Apr; 156(4):728-32. PubMed ID: 17493072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis.
    Emer JJ; Frankel A; Sohn A; Lebwohl M
    J Drugs Dermatol; 2011 Jul; 10(7):735-43. PubMed ID: 21720655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohort.
    Simon D; Lübbe J; Wüthrich B; Wiesner A; Weber MM; Laffitte E; Anliker MD; Schöni MH; Braathen LR; Schmid-Grendelmeier P; Gilgen Bobalj N; Schneider D
    Dermatology; 2006; 213(4):313-8. PubMed ID: 17135737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of topical tacrolimus and pimecrolimus to treat psoriasis: a review.
    Scheinfeld N
    Dermatol Online J; 2004 Jul; 10(1):3. PubMed ID: 15347485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study.
    Cicek D; Kandi B; Bakar S; Turgut D
    J Dermatolog Treat; 2009; 20(6):344-9. PubMed ID: 19954391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.